Briton researchers have found that group of drugs, which act to reduce levels of cholesterol in the blood, is linked to improved heart structure and its function.
According to the study, statins are associated with improved heart structure and function.
Lead author Dr Nay Aung from Queen Mary University of London said that statins are primarily used to lower cholesterol. They are highly effective in preventing cardiovascular events in patients who have had a heart attack or are at risk of heart disease.
He added that statins have other beneficial, non-cholesterol lowering effects. They can improve the function of the blood vessels, reduce inflammation and stabilise fatty plaques in the blood vessels.
They investigated 4,622 people without cardiovascular disease from the UK Biobank, a large community-based cohort study.
Cardiac magnetic resonance imaging was used to measure left and right ventricular volumes and left ventricular mass.
Information on statin use was obtained from medical records and a self-reporting questionnaire.
Nearly 17 percent of participants were taking statins.
Those taking statins were older, had higher BMI and blood pressure and were more likely to have diabetes and hypertension.
"This was not surprising because we prescribe statins to patients at high risk of heart disease and these are all known risk factors," said Dr Aung.
The patients, who were taking statins, had a 2.4 percent lower left ventricular mass and lower left and right ventricular volumes.
They explained that the people, who use statins, were less likely to have a thickened heart muscle (left ventricular hypertrophy) and less likely to have a large heart chamber.
The researchers explained that having a thick, large heart is a strong predictor of future heart attack, heart failure or stroke and taking statins appears to reverse the negative changes in the heart which, in turn, could lower the risk of adverse outcomes.
"It is important to note that in our study, the people taking statins were at higher risk of having heart problems than those not using statins yet they still had positive heart remodelling compared to the healthier control group," added Dr Aung.
Dr Aung said several studies have demonstrated that statins reduce oxidative stress and dampen the production of growth factors which stimulate cell growth.
Statins also increase the production of nitric oxide by the cells lining the blood vessels, leading to vasodilatation, improved blood flow, lower blood pressure, and lower stress on the heart, which is less likely to become hypertrophied.
The findings raise the issue of extending statin prescriptions to anyone above the age of 40, but Dr Aung said that was probably not the way to go.
The findings were presented today at EuroCMR 2017 in Prague.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
